Pro-Vice Chancellor (Strategic Collaborations and Partnerships), University of Sydney

Board Member, Bionic Vision Australia 

Professor Laurent Rivory is Pro-Vice Chancellor (Strategic Collaborations and Partnerships) at the University of Sydney. Before this appointment he was Director, Research Strategy Office at UNSW. Professor Rivory held the position of Senior Director of Research, Research and Development for six years at Johnson & Johnson Research. In this capacity, he led a number of drug-development and drug-discovery projects, in the fields of virology, cancer, diagnostics, RNA therapeutics and ophthalmology. From 2005 to 2006, Dr Rivory was a member of the Johnson & Johnson DC Ophthalmology Task Force. 

Prior to his involvement in the pharmaceutical industry, Professor Rivory was a successful research leader in the field of cancer pharmacology. From 1997 to 2005, he served as Head of the Cancer Pharmacology Laboratory of the Sydney Cancer Centre, at the Royal Prince Alfred Hospital.

Professor Rivory is a graduate of the Australian Institute of Company Directors (AICD) and carried out his post-doctoral studies as an INSERM-NHMRC Fellow in Bordeaux, on aspects of the pharmacology of the cancer drug irinotecan, which is now known as Camptosar®.

Professor Rivory has consulted for pharmaceutical companies and government regulatory bodies, including the Therapeutic Goods Administration (TGA) and is a past member of the TGA's Pharmaceutical Sub-Committee.